Furthermore, we identified a novel pathway consists of HMGB1, ERK, JNK and Bcl-2 for GEM-induced cytoprotective autophagy, and intervention targeting this pathway may improve the anticancer activity of GEM against bladder cancer. This evidence concerns the gene BCL2 and urinary bladder cancer.